Chemotherapy-induced nausea, vomiting, and fatigue - The role of individual differences related to sensory perception and autonomic reactivity

Psychotherapy and Psychosomatics

Volumn 76, Issue 6, 2007, Pages 376-384

  Zachariae, R ^a,b   Paulsen, K ^a   Mehlsen, M ^a   Jensen, A B ^a   Johansson, A ^a   Von Der Maase, H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Psychooncology Research Unit   (Denmark)

Author keywords

Absorption; Anxiety; Autonomic perception; Cancer; Chemotherapy; Expectation; Fatigue; Nausea; Somatosensory amplification; Vomiting

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ABSORPTION; ADULT; ANXIETY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BREAST CANCER; CANCER ADJUVANT THERAPY; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; FATIGUE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; SENSORY STIMULATION; SOMATOSENSORY SYSTEM; UNIVARIATE ANALYSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; AROUSAL; AUTONOMIC NERVOUS SYSTEM; AWARENESS; BIOLOGICAL AVAILABILITY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; FATIGUE; FEMALE; FLUOROURACIL; HUMANS; INDIVIDUALITY; METHOTREXATE; MIDDLE AGED; NAUSEA; PERSONALITY INVENTORY; RISK FACTORS; SENSORY THRESHOLDS; SICK ROLE; SOMATOFORM DISORDERS; STATISTICS AS TOPIC; VOMITING;

EID: 34948878116     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107566     Document Type: Article

References (52)

1. Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J: Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer 1997;5:307-313.
2. Morrow GR, Roscoe JA, Hickok JT, Andrews PR, Matteson S: Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer 2002;10:96-105.
3. Morrow GR, Roscoe JA, Hickok: Nausea and vomiting; in Holland JC (ed): Psycho-Oncology, ed 2. New York, Oxford University Press, 1998, pp 476-484.
4. Iop A, Manfredi AM, Bonura S: Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol 2004;15:712-720.
5. Schnell FM: Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist 2003;8:187-198.
6. Jordan K, Kasper C, Schmoll HJ: Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer 2005;41:199-205.
7. Kaiser R, Sezer O, Papies A, Bauer S, Schelenz C, Tremblay PB, Possinger K, Roots I, Brockmoller J: Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J Clin Oncol 2002;20:2805-2811.
8. Andrykowski MA, Gregg ME: The role of psychological variables in post-chemotherapy nausea: anxiety and expectation. Psychosom Med 1992;54:48-58.
9. Jacobsen PB, Bovbjerg DH, Redd WH: Anticipatory anxiety in women receiving chemotherapy for breast cancer. Health Psychol 1993;12:469-475.
10. Passik SD, Kirsh KL, Rosenfeld B, McDonald MV, Theobald DE: The changeable nature of patients' fears regarding chemotherapy: implications for palliative care. J Pain Symptom Manage 2001;21:113-120.
11. Rabin C, Ward S, Leventhal H, Schmitz M: Explaining retrospective reports of symptoms in patients undergoing chemotherapy: anxiety, initial symptom experience, and posttreatment symptoms. Health Psychol 2001;20:91-98.
12. Molassiotis A, Yam BM, Yung H, Chan FY, Mok TS: Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer 2002;10:139-145.
13. Roscoe JA, Bushunow P, Morrow GR, Hickok JT, Kuebler PJ, Jacobs A, Banerjee TK: Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer 2004;101:2701-2708.
14. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR: Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743-753.
15. Yan H, Sellick K: Symptoms, psychological distress, social support, and quality of life of Chinese patients newly diagnosed with gastrointestinal cancer. Cancer Nurs 2004;27:389-399.
16. Jacobsen PB, Andrykowski MA, Thors CL: Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol 2004;72:355-361.
17. Greenberg DB: Fatigue; in Holland JC (ed): Psycho-Oncology, ed 2. New York, Oxford University Press, 1998, pp 485-493.
18. Cella D: Factors influencing quality of life in cancer patients: anemia and fatigue. Seminars Oncol 1998;25(suppl 7):43-46.
19. Shields SA: Reports of bodily change in anxiety, sadness, and anger. Motiv Emot 1984;8:1-21.
20. Bailer J, Rist F, Witthöft M, Paul C, Bayerl C: Symptom patterns, and perceptual and cognitive styles in subjects with multiple chemical sensitivity (MCS). J Environm Psychol 2004;24:517-525.
21. Houtveen JH, Rietveld S, de Geus EJC: Exaggerated perception of normal physiological responses to stress and hypercapnia in young women with numerous functional somatic symptoms. J Psychosom Res 2003;55:481-490.
22. Sjöden PO, Olafsdottir M, Steinholtz L: Correlates of anxiety, taste and odor experiences in chemotherapy cancer patients. Scan J Behav Ther 1987;16:59-67.
23. Challis GB, Stam HJ: A longitudinal study of the development of anticipatory nausea and vomiting in cancer chemotherapy patients: the role of absorption and autonomic perception. Health Psychol 1992;11:181-189.
24. Barsky AJ: Amplification, somatization, and the somatoform disorders. Psychosomatics 1992;33:28-34.
25. Nakao M, Barsky AJ, Kumano H, Kuboki T: Relationship between somatosensory amplification and alexithymia in a Japanese psychosomatic clinic. Psychosomatics 2002;43:55-60.
26. Tellegen A, Atkinson G: Openness to absorbing and self-altering experiences ('absorption'), a trait related to hypnotic susceptibility. J Abn Psychol 1974;83:268-277.
27. Zachariae R, Jorgensen MM, Christensen S: Hypnotizability and absorption in a Danish sample: testing the influence of context. Int J Clin Exp Hypn 2000;48:306-314.
28. Roche SM, McKonkey KM: Absorption: nature, assessment, and correlates. J Pers Soc Psychol 1990;59:91-101.
29. Tellegen A, Lykken DT, Bouchard TJ, Wilcox KJ, Segal NL, Rich S: Personality similarity in twins reared apart and together. J Pers Soc Psychol 1988;54:1031-1039.
30. Gick M, McLeod C, Hulihan D: Absorption, social desirability, and symptoms in a behavioral medicine population. J Nerv Ment Dis 1997;185:454-458.
31. Vassend O: Dimensions of negative affectivity, self-reported somatic symptoms, and health-related behaviors. Soc Sci Med 1989;28:29-36.
32. Lillienfeld SO: The relation of anxiety sensitivity to higher and lower order personality dimensions: implications for the etiology of panic attacks. J Abnorm Psychol 1997;106:539-544.
33. Ehrnrooth E, Zacharia R, Svendsen G, Jorgensen MM, Yishay M, Sorensen BS, Hjelm Poulsen J, von der Maase H: Increased thymidylate synthase mRNA concentration in blood leukocytes following an experimental stressor. Psychother Psychosom 2002;71:97-103.
34. Zachariae R, Jorgensen MM, Bjerring P, Svendsen G: Autonomic and psychological responses to an acute psychological stressor and relaxation: the influence of hypnotiz-ability and absorption. Int J Clin Exp Hypn 2000;48:388-403.
35. Tellegen A, Atkinson G: Openness to absorbing and self-altering experiences ('absorption'), a trait related to hypnotic susceptibility. J Abnorm Psychol 1974;83:268-277.
36. Barsky AJ, Wyshak G, Klerman GL: The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 1990;24:323-334.
37. Shields SA, Simon A: Is awareness of bodily change in emotion related to awareness of other bodily processes? J Pers Assess 1991;57:96-109.
38. Taylor JA: A personality scale of manifest anxiety. J Abnorm Soc Psychol 1953;48:285-290.
39. Bendig AW: The development of a short form of the Manifest Anxiety Scale. J Consult Psychol 1956;20:384.
40. Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S: A brief POMS measure of distress for cancer patients. J Chron Dis 1987;40:939-942.
41. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
42. Groenvold M, Klee MC, Sprangers MA, Aaronson NK: Validation of the EORTC QLQC30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997;50:441-450.
43. Fujii M, Ohno Y, Tokumaru Y, Imanishi Y, Kanke M, Tomita T, Kanzaki J: Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer. Support Care Cancer 2001;9:366-371.
44. Aronson KR, Barrett LF, Quigley KS: Feeling your body or feeling badly: evidence for the limited validity of the Somatosensory Amplification Scale as an index of somatic sensitivity. J Psychosom Res 2001;51:387-394.
45. Bellg AJ, Morrow GR, Barry M, Angel C, DuBeshter B: Autonomic measures associated with chemotherapy-related nausea: techniques and issues. Cancer Invest 1995;13:313-323.
46. Zachariae R, Jorgensen MM, Christensen S, Bjerring P: Effects of relaxation on the delayed-type hypersensitivity (DTH) reaction to diphenylcyclopropenone (DCP). Allergy 1997;52:760-764.
47. Jorgensen MM, Zachariae R: Autonomic reactivity to cognitive and emotional stress of low, medium, and high hypnotizable healthy subjects: testing predictions from the high risk model of threat perception. Int J Clin Exp Hypn 2002;50:248-275.
48. Carey MP, Burish TG: Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol Bull 1988;104:307-335.
49. Blasco T, Pallares C, Alonso C, Lopez Lopez JJ: The role of anxiety and adaptation to illness in the intensity of postchemotherapy nausea in cancer patients. Span J Psychol 2000;3:47-52.
50. Lee EH, Yae CB, Boog PH, Hong CK: Relationships of mood disturbance and social support to symptom experience in Korean women with breast cancer. J Pain Symptom Manage 2004;27:425-433.
51. Stone P, Richards M, A'Hern R, Hardy J: A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000;11:561-567.
52. Tavio M, Milan I, Tirelli U: Cancer-related fatigue (review). Int J Oncol 2002;21:1093-1099.